newsfilter
← Latest News
GlobeNewswire·

Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings

Combined company to trade on Nasdaq and operate as Fibrx Therapeutics, a fibrosis-focused company led by the Redx management team and boardCompany’s lead program will be RXC008, Redx’s GI-restricted pan-ROCK inhibitor